GeneSeque AS
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
GeneSeque AS - overview
Established
2008
Location
Trondheim, -, Norway
Primary Industry
Biotechnology
About
Based in Norway, Founded in 2008, GeneSeque develops a technology that can enhance the throughput capacity of the next generation DNA-sequencing technologies.
Current Investors
Sarsia
Primary Industry
Biotechnology
Sub Industries
Biotechnology
Company Stage
Early Stage
Total Amount Raised
Subscriber access only
GeneSeque AS - timeline of key events
GeneSeque AS - financials
| Fiscal Year Ended | Dec 31, 2010 | Dec 31, 2011 | Dec 31, 2012 | Dec 31, 2013 | Dec 31, 2014 | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | 1,074,600 | 1,345,900 | 1,720,626 | 837,283 | (200) | - | - | - | 256,000 | 319,500 | 905,001 | 2 | - | - | - |
| % Revenue Growth (YoY) | - | 25.2% | 27.8% | (51.3%) | (100.0%) | 100.0% | - | - | - | 24.8% | 183.3% | (100.0%) | - | - | - |
| EBITDA (USD) | (1,563,722) | (2,833,747) | (4,212,475) | (2,214,186) | (1,439,120) | (405,797) | (317,138) | (360,286) | (115,643) | 237,375 | 829,402 | (27,365) | - | - | - |
| Operating Income (USD) | (1,863,722) | (3,297,927) | (4,685,608) | (2,637,319) | (1,757,451) | (421,097) | (323,060) | (360,286) | (115,643) | 237,375 | 829,402 | (27,365) | - | - | - |
| Operating Margin | (173.4%) | (245.0%) | (272.3%) | (315.0%) | 878725.5% | - | - | - | (45.2%) | 74.3% | 91.6% | (1368250.0%) | - | - | - |
| % EBITDA Margin | (145.5%) | (210.5%) | (244.8%) | (264.4%) | 719560.0% | - | - | - | (45.2%) | 74.3% | 91.6% | (1368250.0%) | - | - | - |
| NET Income (USD) | (1,271,154) | (2,807,724) | (3,638,527) | (2,632,053) | (1,756,860) | (424,105) | (323,974) | (372,957) | (126,424) | 227,401 | 829,402 | (27,365) | - | - | - |
| % Net Margin | (118.3%) | (208.6%) | (211.5%) | (314.4%) | 878430.0% | - | - | - | (49.4%) | 71.2% | 91.6% | (1368250.0%) | - | - | - |
GeneSeque AS - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.